Download FREE Report Sample
Download Free sampleUbenimex (also known as bestatin) is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.
Ubenimex Market contains market size and forecasts of Ubenimex in global, including the following market information:
Global Ubenimex Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ubenimex Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Ubenimex companies in 2021 (%)
The global Ubenimex market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ubenimex include Nippon Kayaku, Eiger BioPharma, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Sinopharm, Xi'an Wanlong Pharmaceutical, Sichuan Luye Pharmaceutical, Chengdu Yuandong Biopharmaceutical and Zhejiang Puluo Kangyu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ubenimex manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ubenimex Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Ubenimex Market Segment Percentages, by Type, 2021 (%)
Tablets
Capsule
Global Ubenimex Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Ubenimex Market Segment Percentages, by Application, 2021 (%)
Cancer
Edema
High Blood Pressure
Other
Global Ubenimex Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Ubenimex Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ubenimex revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ubenimex revenues share in global market, 2021 (%)
Key companies Ubenimex sales in global market, 2017-2022 (Estimated), (KG)
Key companies Ubenimex sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nippon Kayaku
Eiger BioPharma
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Sinopharm
Xi'an Wanlong Pharmaceutical
Sichuan Luye Pharmaceutical
Chengdu Yuandong Biopharmaceutical
Zhejiang Puluo Kangyu Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
